Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions
Manager:
Search and click to pin securities to the top
Page 10 of 11
LEXICON PHARMACEUTICALS, INC.
Shares:1.2M
Value:$530.0K
Passage BIO, Inc.
Shares:1.5M
Value:$529.6K
Outlook Therapeutics, Inc.
Shares:400.0K
Value:$488.0K
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Shares:510.3K
Value:$486.8K
BioAtla, Inc.
Shares:1.4M
Value:$476.5K
Atara Biotherapeutics, Inc.
Shares:75.2K
Value:$446.7K
STANDARD BIOTOOLS INC.
Shares:407.8K
Value:$440.4K
Century Therapeutics, Inc.
Shares:900.0K
Value:$428.4K
Amylyx Pharmaceuticals, Inc.
Shares:100.0K
Value:$354.0K
CASSAVA SCIENCES INC
Shares:200.0K
Value:$300.0K
GRAIL, Inc.
Shares:11.3K
Value:$288.6K
Kodiak Sciences Inc.
Shares:100.0K
Value:$280.5K
MACROGENICS INC
Shares:218.9K
Value:$277.9K
Quince Therapeutics, Inc.
Shares:184.4K
Value:$245.2K
Invivyd, Inc.
Shares:400.0K
Value:$242.1K
NextCure, Inc.
Shares:404.1K
Value:$194.1K
Metagenomi, Inc.
Shares:135.0K
Value:$183.6K
008064107
Shares:69.8K
Value:$175.1K
Athira Pharma, Inc.
Shares:600.0K
Value:$170.9K
Seres Therapeutics, Inc.
Shares:203.9K
Value:$142.8K